RIMPOVIZ
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Oct 2024)
What this means for you
This application is over — abandoned 21 Oct 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97418690
- Mark type
- Stylized text
- Filed
- 19 May 2022
- Published for opposition
- 17 Jan 2023
- Abandoned
- 21 Oct 2024
- Attorney of record
- Douglas A. Rettew
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthalmologic pharmaceutical preparations
Owner
- BIOGEN INTERNATIONAL GMBH, BAAR, CH
- Biogen MA Inc., Boston, MA, US
- Biogen MA Inc., Boston, MA, US
Prosecution history
- 21 Oct 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Oct 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 30 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2023 — SOU EXTENSION 2 GRANTED
- 29 Nov 2023 — SOU EXTENSION 2 FILED
- 29 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 22 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2023 — SOU EXTENSION 1 GRANTED
- 18 Aug 2023 — SOU EXTENSION 1 FILED
- 18 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 14 Mar 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jan 2023 — PUBLISHED FOR OPPOSITION
- 28 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED